Results 241 to 250 of about 1,295,645 (274)

Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
The mechanisms of SeNPs therapy in cancer treatment, encompass three parallel actions: (1) seleno‐amino acids, key metabolites, upregulate GPX2 expression, thereby inhibiting tumor metastasis via the GPX2‐HIF1α‐VEGF signaling pathway; (2) selenite (SeO32−), an inorganic metabolite, forms hydrogen bonds with amino acid residues 13–17 of the KRAS G13D ...
Xiaoting Liu   +13 more
wiley   +1 more source

Plasma cells - a key target in antibody-mediated diseases. [PDF]

open access: yesCell Mol Life Sci
Fiebig L   +9 more
europepmc   +1 more source

SIRPA drives T cell apoptosis to promote immune evasion in hepatocellular carcinoma. [PDF]

open access: yesJ Immunother Cancer
Zhang X   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Defects in Intrinsic and Innate Immunity

Rare Diseases of the Immune System, 2021
The defects in intrinsic and innate immunity are a group of monogenic diseases in which there is a numeric and/or functional defect of the cellular components of innate immunity, not included in phagocyte defects or complement defects. It is a very diverse group of primary immunodeficiencies (PID) or inborn errors of immunity (IEI), both ...
Ruben Martinez-Barricarte   +2 more
exaly   +5 more sources

Home - About - Disclaimer - Privacy